Chandan Healthcare Ltd

NSE: CHANDAN · Other · sector

₹227.90NSE close 2026-10-26

Key numbers

Market cap₹557 cr

Price₹227.90

52w high / low₹358 / ₹185

P/E14.2xSector median 14.4x

P/B3.8xSector median 1.7x

Book value₹59.5

Dividend yield–Sector median 0.37%

ROE32.1%Sector median 13.8%

ROCE47.2%Sector median 19.6%

OPM18.7%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA6.9xSector median 8.4x

Interest cover5.7x

Current ratio2.13x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 5.7x in the last 12 months.
Other income was 17% of net profit in the last 12 months.
No dividend in the last 2 financial years.
Price ₹227.90 on 2026-10-26: -36.3% from the 52-week high, +22.9% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹338.55 · low ₹149.70

Quarterly results

₹ cr	Mar 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	120	136	65	141	81
EBITDA	21	28	10	21	20
OPM %	18.0%	20.8%	14.8%	15.2%	24.2%
Other income	1	2	1	3	1
Net profit	12	16	5	11	8
EPS (₹)	5.60	6.38	1.86	4.69	3.07
Revenue YoY					-32.4%
Profit YoY					-35.0%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY25	FY26	TTM
Revenue	230	276	422
EBITDA	41	50	79
Net profit	22	27	39
EPS (₹)	10.78	11.07	16.00
Revenue growth		+20.1%	–
Profit growth		+22.1%	–
Dividend / share (₹)	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	– (2y)	-29.1%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	98	145
Cash & equivalents	6	16
Total assets	211	290
Fixed assets	72	97
Investments	1	8
Inventory	31	34

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-29	16
Cash from investing	-36	-40
Cash from financing	67	21
Capex	39	43
Free cash flow	-68	-26

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	22.6%	18.6%
ROCE %	37.3%	30.4%
Inventory days	106	92
Working capital days	85	115

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
CHANDAN	₹557 cr	14.2x	3.8x	32.1%	47.2%	18.7%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	CHANDAN
BSE code	–
ISIN	INE0B2N01016
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.